SCHEMBL8770314

SCHEMBL8770314

ClCCCCOc1ccc(C(=Cc2ccccc2)c2ccc(OCc3ccccc3)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 2/20 0.59
▸ CYP19A1 P11511 1/20 0.59
▸ ESR2 Q92731 1/20 0.59
▸ CYP2D6 P10635 1/20 0.55
▸ PSMB1 P20618 1/20 0.52
▸ PSMB5 P28074 1/20 0.52
▸ PSMB2 P49721 1/20 0.52
▸ NR4A1 P22736 1/20 0.49
▸ NR4A2 P43354 1/20 0.49
▸ NR4A3 Q92570 1/20 0.49
▸ NR1H4 Q96RI1 1/20 0.47
▸ MAOB P27338 1/20 0.47
▸ PARP10 Q53GL7 1/20 0.47
▸ LMNA P02545 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ PTGS1 P23219 1/20 0.46
▸ SLC6A2 P23975 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ PTGS2 P35354 1/20 0.46
▸ SLC6A3 Q01959 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9838120 0.82 KDM4E (0.61) ESR1CYP19A1ESR2CYP2D6NR4A1
SCHEMBL9838123 0.82 KDM4E (0.61) ESR1CYP19A1ESR2CYP2D6NR4A1
SCHEMBL8770271 0.81 SRD5A2 (0.70) NR4A1NR4A2NR4A3MAOBPARP10
SCHEMBL9839479 0.80 KDM4E (0.66) ESR1CYP19A1ESR2CYP2D6NR4A1
SCHEMBL9837797 0.80 KDM4E (0.66) ESR1CYP19A1ESR2CYP2D6NR4A1
SCHEMBL9839473 0.80 KDM4E (0.66) ESR1CYP19A1ESR2CYP2D6NR4A1
SCHEMBL4094384 0.78 LMNA (0.62) NR4A1NR4A2NR4A3MAOBLMNA
SCHEMBL8770160 0.77 ESR1 (0.55) ESR1CYP19A1ESR2CYP2D6NR4A1
SCHEMBL4747432 0.76 ESR1 (0.55) ESR1CYP19A1ESR2CYP2D6PSMB1
SCHEMBL4747435 0.76 ESR1 (0.55) ESR1CYP19A1ESR2CYP2D6PSMB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1167437-A Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis HOECHST MARION ROUSSEL INC (US) 1997-12-10 — — CN disclosed
US-5693674-A Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis HOECHST MARION ROUSSEL, INC. (US) 1997-12-02 — — US disclosed
US-5691384-A Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis HOECHST MARION ROUSSEL, INC. (US) 1997-11-25 — — US disclosed
EP-0794771-A1 METHOD OF USING TRIARYL-ETHYLENE DERIVATIVES IN THE TREATMENT AND PREVENTION OF OSTEOPOROSIS HOECHST MARION ROUSSEL, INC. (US) 1997-09-17 — — EP disclosed
WO-1996016646-A1 METHOD OF USING TRIARYL-ETHYLENE DERIVATIVES IN THE TREATMENT AND PREVENTION OF OSTEOPOROSIS HOECHST MARION ROUSSEL, INC. (US) 1996-06-06 — — WO disclosed
Send feedback